{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:25:23Z","timestamp":1790144723788,"version":"4.0.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To investigate the rate of the recurrence of cystoid macular edema (CME) secondary to retinitis pigmentosa (RP) after the initiation of topical dorzolamide and the recurrence risk factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We retrospectively analyzed the data of RP patients at Kyushu University Hospital. We included patients who showed a treatment response to 1.0% topical dorzolamide. The day of treatment initiation was set as the baseline. Topical dorzolamide treatment was continued during the follow-up. The recurrence of CME (defined as a &gt;20% increase in central subfield thickness compared to previous visit, or a central subfield thickness value that exceed baseline value) was evaluated at each follow-up visit. Risk factors for RP-CME recurrence were analyzed by Cox proportional hazards modeling. A Kaplan\u2013Meier survival analysis was used to evaluate the time to recurrent RP-CME.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Forty RP-CME patients showed a treatment response to topical dorzolamide. During the mean 3.9-year follow-up, 14 patients exhibited recurrence; its rate was 15.6%, 34.7%, and 48.7% at 1, 3, and 5 years, respectively. A high baseline central subfield thickness was significantly associated with recurrent (hazard ratio 1.11, 95% CI: 1.05\u20131.18, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0004).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The recurrence rate of RP-CME increased with time. A high baseline central subfield thickness value was a risk factor for recurrence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003286","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T01:13:33Z","timestamp":1629076413000},"page":"168-173","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["RECURRENCE RATE OF CYSTOID MACULAR EDEMA WITH TOPICAL DORZOLAMIDE TREATMENT AND ITS RISK FACTORS IN RETINITIS PIGMENTOSA"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7255-3443","authenticated-orcid":false,"given":"Shotaro","family":"Shimokawa","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohta","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Funatsu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Nakatake","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Koyanagi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Clinical Research Center, Faculty of Medicine, University of Saga, Saga, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsunobu","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-Hei","family":"Sonoda","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/bjo.2008.138560","article-title":"The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography","volume":"92","author":"Hajali","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/IAE.0000000000000010","article-title":"Prevalence and spatial distribution of cystoid spaces in retinitis pigmentosa: investigation with spectral domain optical coherence tomography","volume":"34","author":"Makiyama","year":"2014","journal-title":"Retina"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archopht.1989.01070020519031","article-title":"Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa","volume":"107","author":"Fishman","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00006982-199717030-00009","article-title":"Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa","volume":"17","author":"Grover","year":"1997","journal-title":"Retina"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/IAE.0b013e31805f6b79","article-title":"Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa","volume":"27","author":"Apushkin","year":"2007","journal-title":"Retina"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1167\/iovs.14-15995","article-title":"Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa","volume":"56","author":"Liew","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ajo.2005.12.030","article-title":"Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa","volume":"141","author":"Grover","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/bjo.2006.107466","article-title":"Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa","volume":"91","author":"Fishman","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1001\/archophthalmol.2010.172","article-title":"Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome","volume":"128","author":"Genead","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00417-011-1904-5","article-title":"The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa","volume":"250","author":"Ikeda","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/bjophthalmol-2012-303005","article-title":"Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa","volume":"97","author":"Ikeda","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"e000107","DOI":"10.1136\/bmjophth-2017-000107","article-title":"Efficacy of additional topical betamethasone in persistent cystoid macular oedema after carbonic anhydrase inhibitor treatments in retinitis pigmentosa","volume":"3","author":"Kitahata","year":"2018","journal-title":"BMJ Open Ophthalmol"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0420.2005.00395.x","article-title":"Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa","volume":"83","author":"Ozdemir","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/IAE.0000000000001542","article-title":"Intravitreal dexamethasone implant in retinitis pigmentosa\u2013related cystoid macular edema","volume":"38","author":"Mansour","year":"2018","journal-title":"Retina"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/IAE.0000000000002944","article-title":"Microstructural changes in cystoid macular edema in retinitis pigmentosa after intravitreal dexamethasone implant injection","volume":"41","author":"Park","year":"2020","journal-title":"Retina"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1089\/jop.2018.0153","article-title":"Dexamethasone implant produces better outcomes than oral acetazolamide in patients with cystoid macular edema secondary to retinitis pigmentosa","volume":"36","author":"Veritti","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/02713680802710692","article-title":"Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa","volume":"34","author":"Yuzbasioglu","year":"2009","journal-title":"Curr Eye Res"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/bjophthalmol-2019-315152","article-title":"Prospective exploratory study to assess the safety and efficacy of aflibercept in cystoid macular oedema associated with retinitis pigmentosa","volume":"104","author":"Strong","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.oret.2020.05.012","article-title":"Effect of topical dorzolamide on cystoid macular edema in retinitis pigmentosa","volume":"4","author":"Shimokawa","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/jmedgenet-2018-105691","article-title":"Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients","volume":"56","author":"Koyanagi","year":"2019","journal-title":"J Med Genet"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1038\/s41598-018-26231-9","article-title":"Assessment of central visual function in patients with retinitis pigmentosa","volume":"8","author":"Fujiwara","year":"2018","journal-title":"Sci Rep"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archopht.1988.01060140350030","article-title":"Treatment of chronic macular edema with acetazolamide","volume":"106","author":"Cox","year":"1988","journal-title":"Arch Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:06:36Z","timestamp":1749319596000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003286","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}